Secondary Prevention After Coronary Artery Bypass Graft Surgery

Author:

Williams Judson B.1,DeLong Elizabeth R.1,Peterson Eric D.1,Dokholyan Rachel S.1,Ou Fang-Shu1,Ferguson T. Bruce1

Affiliation:

1. From the Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC (J.B.W., E.R.D., E.D.P., R.S.D., F.S.O.), and the Department of Cardiovascular Sciences, Brody School of Medicine and East Carolina Heart Institute, East Carolina University, Greenville, NC (T.B.F.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Paper presented at: ASQC 40th Annual Quality Congress Anaheim CA May 20 1986 Paper presented at: ASQC 40th Annual Quality Congress 19 JM Juran The quality trilogy: a universal approach to managing for quality 1986 19 24

2. Crosby PB. Let's Talk Quality: 98 Questions You Always Wanted to Ask Phil Crosby. New York NY: McGraw-Hill; 1989.

3. Use of Continuous Quality Improvement to Increase Use of Process Measures in Patients Undergoing Coronary Artery Bypass Graft Surgery

4. Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3